| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 7.03e-07 | 4 | 113 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 9.32e-07 | 14 | 113 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 9.47e-06 | 24 | 113 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 9.68e-06 | 8 | 113 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 9.68e-06 | 8 | 113 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.54e-05 | 27 | 113 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 2.82e-05 | 11 | 113 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 3.17e-05 | 2 | 113 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 3.17e-05 | 2 | 113 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 3.17e-05 | 2 | 113 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 3.17e-05 | 2 | 113 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | aromatase activity | 4.45e-05 | 35 | 113 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 7.64e-05 | 15 | 113 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.69e-04 | 49 | 113 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 1.89e-04 | 4 | 113 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 1.89e-04 | 4 | 113 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 3.14e-04 | 5 | 113 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 3.14e-04 | 5 | 113 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 3.14e-04 | 5 | 113 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 8.31e-04 | 194 | 113 | 6 | GO:0016705 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 9.29e-04 | 34 | 113 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 1.10e-03 | 36 | 113 | 3 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 1.10e-03 | 36 | 113 | 3 | GO:0015662 | |
| GeneOntologyMolecularFunction | damaged DNA binding | 1.32e-03 | 84 | 113 | 4 | GO:0003684 | |
| GeneOntologyMolecularFunction | P-type sodium transporter activity | 1.39e-03 | 10 | 113 | 2 | GO:0008554 | |
| GeneOntologyMolecularFunction | P-type sodium:potassium-exchanging transporter activity | 1.39e-03 | 10 | 113 | 2 | GO:0005391 | |
| GeneOntologyMolecularFunction | P-type potassium transmembrane transporter activity | 1.69e-03 | 11 | 113 | 2 | GO:0008556 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 1.69e-03 | 11 | 113 | 2 | GO:0004983 | |
| GeneOntologyMolecularFunction | heme binding | 1.84e-03 | 154 | 113 | 5 | GO:0020037 | |
| GeneOntologyMolecularFunction | exonuclease activity | 1.85e-03 | 92 | 113 | 4 | GO:0004527 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 2.02e-03 | 12 | 113 | 2 | GO:0003953 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.42e-03 | 164 | 113 | 5 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.55e-03 | 166 | 113 | 5 | GO:0005506 | |
| GeneOntologyMolecularFunction | hormone binding | 2.80e-03 | 103 | 113 | 4 | GO:0042562 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 PCDHGB7 ENPP2 PCDHB15 PCDHB8 PKDREJ EPS15L1 FAT2 CDH22 PLCD1 CDH3 | 3.47e-03 | 749 | 113 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 3.62e-03 | 16 | 113 | 2 | GO:0061809 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 5.59e-06 | 22 | 112 | 4 | GO:0019373 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 PCDHGB7 PCDHB15 PCDHB8 IL1RAPL1 FAT2 CDH22 CLDN20 CDH3 | 5.32e-05 | 313 | 112 | 9 | GO:0098742 |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 5.43e-05 | 14 | 112 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 7.31e-05 | 187 | 112 | 7 | GO:0007156 | |
| MousePheno | abnormal cranium size | 2.31e-06 | 97 | 87 | 7 | MP:0010031 | |
| MousePheno | decreased neocortex volume | 3.83e-05 | 2 | 87 | 2 | MP:0020070 | |
| MousePheno | small cranium | 5.63e-05 | 34 | 87 | 4 | MP:0005352 | |
| Domain | LRRC37AB_C | 9.30e-07 | 4 | 116 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 9.30e-07 | 4 | 116 | 3 | PF14914 | |
| Domain | LRRC37_N | 9.30e-07 | 4 | 116 | 3 | IPR032754 | |
| Domain | LRRC37 | 9.30e-07 | 4 | 116 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 9.30e-07 | 4 | 116 | 3 | IPR015753 | |
| Domain | Cadherin_CS | 5.25e-06 | 109 | 116 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 6.67e-06 | 113 | 116 | 7 | PS00232 | |
| Domain | Cadherin | 6.67e-06 | 113 | 116 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 7.07e-06 | 114 | 116 | 7 | PS50268 | |
| Domain | - | 7.07e-06 | 114 | 116 | 7 | 2.60.40.60 | |
| Domain | CA | 7.49e-06 | 115 | 116 | 7 | SM00112 | |
| Domain | Cadherin-like | 7.93e-06 | 116 | 116 | 7 | IPR015919 | |
| Domain | Cadherin | 8.87e-06 | 118 | 116 | 7 | IPR002126 | |
| Domain | LRR_8 | 1.15e-05 | 171 | 116 | 8 | PF13855 | |
| Domain | LRR_TYP | 1.48e-05 | 177 | 116 | 8 | SM00369 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.48e-05 | 177 | 116 | 8 | IPR003591 | |
| Domain | RBB1NT | 3.82e-05 | 2 | 116 | 2 | PF08169 | |
| Domain | Znf-C4pol | 3.82e-05 | 2 | 116 | 2 | IPR025687 | |
| Domain | RBB1NT | 3.82e-05 | 2 | 116 | 2 | IPR012603 | |
| Domain | NPY4_rcpt | 3.82e-05 | 2 | 116 | 2 | IPR001933 | |
| Domain | zf-C4pol | 3.82e-05 | 2 | 116 | 2 | PF14260 | |
| Domain | - | 1.01e-04 | 15 | 116 | 3 | 1.10.150.60 | |
| Domain | BRIGHT | 1.01e-04 | 15 | 116 | 3 | SM00501 | |
| Domain | ARID_dom | 1.01e-04 | 15 | 116 | 3 | IPR001606 | |
| Domain | ARID | 1.01e-04 | 15 | 116 | 3 | PS51011 | |
| Domain | ARID | 1.01e-04 | 15 | 116 | 3 | PF01388 | |
| Domain | - | 1.14e-04 | 3 | 116 | 2 | 3.90.1600.10 | |
| Domain | DNA_pol_palm_dom | 1.14e-04 | 3 | 116 | 2 | IPR023211 | |
| Domain | DNA_POLYMERASE_B | 1.14e-04 | 3 | 116 | 2 | PS00116 | |
| Domain | DNA-dir_DNA_pol_B_CS | 1.14e-04 | 3 | 116 | 2 | IPR017964 | |
| Domain | ATPase_P-typ_TM_dom | 1.23e-04 | 16 | 116 | 3 | IPR023298 | |
| Domain | - | 1.23e-04 | 16 | 116 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.49e-04 | 17 | 116 | 3 | IPR006068 | |
| Domain | Cation_ATPase_C | 1.49e-04 | 17 | 116 | 3 | PF00689 | |
| Domain | Cyt_P450_E_grp-I | 1.73e-04 | 45 | 116 | 4 | IPR002401 | |
| Domain | DNA_pol_B | 2.28e-04 | 4 | 116 | 2 | PF00136 | |
| Domain | DNA-dir_DNA_pol_B | 2.28e-04 | 4 | 116 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 2.28e-04 | 4 | 116 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 2.28e-04 | 4 | 116 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 2.28e-04 | 4 | 116 | 2 | PF03104 | |
| Domain | POLBc | 2.28e-04 | 4 | 116 | 2 | SM00486 | |
| Domain | LRR | 2.61e-04 | 201 | 116 | 7 | PS51450 | |
| Domain | Leu-rich_rpt | 2.91e-04 | 271 | 116 | 8 | IPR001611 | |
| Domain | Cyt_P450_CS | 3.27e-04 | 53 | 116 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 4.33e-04 | 57 | 116 | 4 | PS00086 | |
| Domain | LRR_1 | 4.38e-04 | 219 | 116 | 7 | PF00560 | |
| Domain | - | 4.63e-04 | 58 | 116 | 4 | 1.10.630.10 | |
| Domain | p450 | 4.63e-04 | 58 | 116 | 4 | PF00067 | |
| Domain | Cyt_P450 | 5.27e-04 | 60 | 116 | 4 | IPR001128 | |
| Domain | Tudor-knot | 5.64e-04 | 6 | 116 | 2 | PF11717 | |
| Domain | Tudor-knot | 5.64e-04 | 6 | 116 | 2 | IPR025995 | |
| Domain | P-type_ATPase_IIC | 5.64e-04 | 6 | 116 | 2 | IPR005775 | |
| Domain | - | 8.89e-04 | 321 | 116 | 8 | 3.80.10.10 | |
| Domain | L_dom-like | 1.02e-03 | 328 | 116 | 8 | IPR032675 | |
| Domain | NPY_rcpt | 1.34e-03 | 9 | 116 | 2 | IPR000611 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.56e-03 | 37 | 116 | 3 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.56e-03 | 37 | 116 | 3 | PF00122 | |
| Domain | IL-1_rcpt_fam | 2.03e-03 | 11 | 116 | 2 | IPR015621 | |
| Domain | Tyr_kinase_rcpt_2_CS | 2.03e-03 | 11 | 116 | 2 | IPR002011 | |
| Domain | Cadherin_C | 2.25e-03 | 42 | 116 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 2.25e-03 | 42 | 116 | 3 | PF16492 | |
| Domain | RECEPTOR_TYR_KIN_II | 2.42e-03 | 12 | 116 | 2 | PS00239 | |
| Domain | LRRNT | 3.26e-03 | 98 | 116 | 4 | IPR000372 | |
| Domain | LRRNT | 3.26e-03 | 98 | 116 | 4 | SM00013 | |
| Domain | Bbox_C | 3.81e-03 | 15 | 116 | 2 | IPR003649 | |
| Domain | BBC | 3.81e-03 | 15 | 116 | 2 | SM00502 | |
| Domain | Cation_ATPase_N | 5.48e-03 | 18 | 116 | 2 | PF00690 | |
| Domain | Cation_ATPase_N | 5.48e-03 | 18 | 116 | 2 | SM00831 | |
| Domain | BRCT | 6.10e-03 | 19 | 116 | 2 | PF00533 | |
| Domain | ATPase_P-typ_cation-transptr_N | 6.10e-03 | 19 | 116 | 2 | IPR004014 | |
| Pathway | REACTOME_XENOBIOTICS | 7.46e-06 | 23 | 79 | 4 | M5372 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 9.30e-06 | 8 | 79 | 3 | M27135 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 1.39e-05 | 9 | 79 | 3 | M27143 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 1.95e-05 | 29 | 79 | 4 | M2920 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 2.71e-05 | 11 | 79 | 3 | M27130 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 3.59e-05 | 12 | 79 | 3 | M48064 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 5.90e-05 | 14 | 79 | 3 | MM15842 | |
| Pathway | KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION | 7.34e-05 | 15 | 79 | 3 | M47854 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 2.09e-04 | 21 | 79 | 3 | M39631 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 3.08e-04 | 58 | 79 | 4 | M5410 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 3.15e-04 | 24 | 79 | 3 | M46445 | |
| Pathway | REACTOME_XENOBIOTICS | 3.56e-04 | 25 | 79 | 3 | MM14846 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 3.98e-04 | 62 | 79 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 4.50e-04 | 64 | 79 | 4 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 4.50e-04 | 64 | 79 | 4 | M9488 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 4.58e-04 | 6 | 79 | 2 | M27909 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 6.33e-04 | 70 | 79 | 4 | M16794 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 6.39e-04 | 7 | 79 | 2 | M39515 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 6.39e-04 | 7 | 79 | 2 | MM14856 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 7.04e-04 | 72 | 79 | 4 | M9257 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 8.49e-04 | 8 | 79 | 2 | M27891 | |
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 1.26e-10 | 4 | 118 | 4 | 7704034 | |
| Pubmed | 1.26e-10 | 4 | 118 | 4 | 19706858 | ||
| Pubmed | 1.26e-10 | 4 | 118 | 4 | 2009263 | ||
| Pubmed | 1.26e-10 | 4 | 118 | 4 | 21798861 | ||
| Pubmed | 1.26e-10 | 4 | 118 | 4 | 23755828 | ||
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 3.81e-08 | 3 | 118 | 3 | 10704292 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 35134542 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 3.81e-08 | 3 | 118 | 3 | 21977947 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 23118231 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 28687336 | ||
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 3.81e-08 | 3 | 118 | 3 | 8530044 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 21173785 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 15102943 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 24430292 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 20665013 | ||
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 3.81e-08 | 3 | 118 | 3 | 19954515 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 8095407 | ||
| Pubmed | DCHS2 MYO6 KDM5A ENPP2 MYRIP ZFC3H1 HUNK REV3L SIM2 SEC31B CHUK TRIM33 EPS15L1 UBA7 SYNJ1 CKAP2 ATP1A2 TRIM37 SLX4 | 6.84e-08 | 1285 | 118 | 19 | 35914814 | |
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 1.23e-07 | 14 | 118 | 4 | 19290787 | |
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 22419166 | ||
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 28990182 | ||
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 1.52e-07 | 4 | 118 | 3 | 16025294 | |
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 2.22e-07 | 16 | 118 | 4 | 17048007 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 19415824 | ||
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 3.79e-07 | 5 | 118 | 3 | 20857895 | |
| Pubmed | 3.79e-07 | 5 | 118 | 3 | 15837803 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 5.85e-07 | 20 | 118 | 4 | 9890157 | |
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 7.56e-07 | 6 | 118 | 3 | 17635176 | |
| Pubmed | A genome-wide association study of acenocoumarol maintenance dosage. | 7.56e-07 | 6 | 118 | 3 | 19578179 | |
| Pubmed | 9.73e-07 | 222 | 118 | 8 | 37071664 | ||
| Pubmed | 3.22e-06 | 30 | 118 | 4 | 20529763 | ||
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 23064749 | ||
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 20602612 | ||
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 19651758 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 6.16e-06 | 11 | 118 | 3 | 15469410 | |
| Pubmed | 6.16e-06 | 11 | 118 | 3 | 15039299 | ||
| Pubmed | 8.19e-06 | 12 | 118 | 3 | 15319333 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 7574697 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30562214 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26122864 | ||
| Pubmed | Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. | 1.14e-05 | 2 | 118 | 2 | 12435384 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 1.14e-05 | 2 | 118 | 2 | 18511451 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18694831 | ||
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 1.14e-05 | 2 | 118 | 2 | 14634042 | |
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 1.14e-05 | 2 | 118 | 2 | 10908295 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 1847130 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28513222 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 1.14e-05 | 2 | 118 | 2 | 17599801 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19038035 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15385837 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25518510 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 1.14e-05 | 2 | 118 | 2 | 8333835 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16372821 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15842554 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19136640 | ||
| Pubmed | Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage. | 1.14e-05 | 2 | 118 | 2 | 35748067 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20890775 | ||
| Pubmed | Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development. | 1.14e-05 | 2 | 118 | 2 | 32587777 | |
| Pubmed | Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population. | 1.14e-05 | 2 | 118 | 2 | 17201743 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 32683556 | ||
| Pubmed | Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers. | 1.14e-05 | 2 | 118 | 2 | 18548238 | |
| Pubmed | Identification of chromatin remodeling genes Arid4a and Arid4b as leukemia suppressor genes. | 1.14e-05 | 2 | 118 | 2 | 18728284 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15855721 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19847408 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17504998 | ||
| Pubmed | Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors. | 1.14e-05 | 2 | 118 | 2 | 24519941 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 14623888 | ||
| Pubmed | Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. | 1.14e-05 | 2 | 118 | 2 | 14646690 | |
| Pubmed | Characterization of the retinoblastoma binding proteins RBP1 and RBP2. | 1.14e-05 | 2 | 118 | 2 | 8414517 | |
| Pubmed | Gene structure of CYP2C8 and extrahepatic distribution of the human CYP2Cs. | 1.14e-05 | 2 | 118 | 2 | 10487415 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19480553 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22589111 | ||
| Pubmed | CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population. | 1.14e-05 | 2 | 118 | 2 | 15660966 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18154472 | ||
| Pubmed | Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily. | 1.14e-05 | 2 | 118 | 2 | 15766564 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 27353638 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17298483 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33115391 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21047199 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 17562299 | ||
| Pubmed | Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals. | 1.14e-05 | 2 | 118 | 2 | 16646575 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 36960518 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26690534 | ||
| Pubmed | cDNA and amino acid sequences of two members of the human P450IIC gene subfamily. | 1.14e-05 | 2 | 118 | 2 | 3697070 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19199010 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19381162 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19358898 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34438105 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 2895926 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19935798 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20831536 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16198656 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24288737 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 1.14e-05 | 2 | 118 | 2 | 15569425 | |
| Pubmed | Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. | 1.14e-05 | 2 | 118 | 2 | 22491019 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28686288 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20808793 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22918969 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15606441 | ||
| Interaction | CYP2C19 interactions | 1.84e-06 | 5 | 116 | 3 | int:CYP2C19 | |
| Interaction | DCLRE1A interactions | 4.70e-06 | 20 | 116 | 4 | int:DCLRE1A | |
| Interaction | GGH interactions | 1.16e-05 | 243 | 116 | 9 | int:GGH | |
| Interaction | CYP2C18 interactions | 1.65e-05 | 27 | 116 | 4 | int:CYP2C18 | |
| Interaction | MAGEB18 interactions | 2.96e-05 | 11 | 116 | 3 | int:MAGEB18 | |
| Cytoband | 10q24 | 1.02e-04 | 35 | 118 | 3 | 10q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q14 | 1.19e-04 | 97 | 118 | 4 | chr6q14 | |
| GeneFamily | Cytochrome P450 family 2 | 1.85e-05 | 35 | 82 | 4 | 1001 | |
| GeneFamily | AT-rich interaction domain containing | 3.93e-05 | 15 | 82 | 3 | 418 | |
| GeneFamily | ATPase Na+/K+ transporting subunits | 4.20e-04 | 7 | 82 | 2 | 1208 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 2.05e-03 | 15 | 82 | 2 | 1296 | |
| GeneFamily | Cadherin related | 2.64e-03 | 17 | 82 | 2 | 24 | |
| GeneFamily | Clustered protocadherins | 3.07e-03 | 64 | 82 | 3 | 20 | |
| Coexpression | GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP | 2.85e-07 | 199 | 117 | 9 | M8294 | |
| Coexpression | GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN | 3.35e-06 | 200 | 117 | 8 | M8311 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED | 1.85e-05 | 12 | 117 | 3 | M47998 | |
| Coexpression | FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL | ARID4B ARID4A KDM5A NBEAL1 STK17B UBE2C LGR4 REV3L CSRNP1 MAP3K13 CKAP2 CDH3 | 3.20e-05 | 644 | 117 | 12 | M41717 |
| Coexpression | GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN | 3.21e-05 | 199 | 117 | 7 | M8289 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TREG_DN | 3.31e-05 | 200 | 117 | 7 | M3233 | |
| Coexpression | PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN | 3.55e-05 | 137 | 117 | 6 | M4781 | |
| Coexpression | SMID_BREAST_CANCER_LUMINAL_A_UP | 4.01e-05 | 85 | 117 | 5 | M7517 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KATNAL2 MAN2B1 TMC7 MYO6 NBEAL1 TMEM94 ENPP2 PCDHB8 ZDHHC14 PLEKHN1 ASAP1 ARSB CLCN3 CEP295 HTT TPBG | 4.03e-05 | 1124 | 117 | 16 | MM1070 |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_UP | 4.07e-05 | 43 | 117 | 4 | MM669 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 9.35e-05 | 20 | 117 | 3 | MM1104 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.09e-04 | 417 | 117 | 9 | M39224 | |
| Coexpression | STEIN_ESRRA_TARGETS_DN | 1.10e-04 | 105 | 117 | 5 | M18160 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | KATNAL2 MAN2B1 TMC7 MYO6 NBEAL1 TMEM94 ENPP2 ZDHHC14 PLEKHN1 ASAP1 ARSB CLCN3 CEP295 HTT TPBG | 1.18e-04 | 1102 | 117 | 15 | M2369 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | UBE2J1 KATNAL2 SFRP2 ARID4B ARID4A KDM5A SMC6 TRIM33 EPS15L1 FUT11 KIAA1549L CEP295 CKAP2 | 4.02e-05 | 629 | 116 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | UBE2J1 SFRP2 TMC7 PCDHGB7 MYO6 TMEM94 ENPP2 PCDHB15 PCDHB8 ZFC3H1 RAB11FIP1 SEC31B TP53INP2 IGDCC4 CSRNP1 SNX14 BMP7 CLCN3 ATP1A2 DOP1A TPBG | 4.12e-05 | 1466 | 116 | 21 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | DDX31 ARID4B CENPL ARID4A ENPP2 DDR2 PCDHB15 SIM2 TMTC3 TRIM37 TPBG | 6.30e-05 | 478 | 116 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | DDX31 ARID4B ARID4A ENPP2 DDR2 PCDHB15 SIM2 CNOT6L TMTC3 TRIM37 TPBG | 8.14e-05 | 492 | 116 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.66e-08 | 192 | 118 | 8 | 3a6f2c255da46a0b0f5b657b0f56f3d7798ae85a | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Mesenchymal_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.49e-07 | 181 | 118 | 7 | 7e3bcfa2ba5b98a7df5854aa6e7a31e9a71faa8a | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-07 | 184 | 118 | 7 | fe4d3def3da4ffdea5ae6bb059f5397efd58fef3 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 9.70e-07 | 197 | 118 | 7 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 9.70e-07 | 197 | 118 | 7 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_basal-Dividing_Basal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.70e-07 | 197 | 118 | 7 | 0a6754a5109bec0d0de42adbfdf4db43ff60c3d2 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.00e-06 | 198 | 118 | 7 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 200 | 118 | 7 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-06 | 200 | 118 | 7 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | Basal_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.78e-06 | 168 | 118 | 6 | 48089fa2d4a0f31a72405717119b767a92571f01 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-06 | 177 | 118 | 6 | e55d21d4d61a069b9bbe0e7595fbfb7cfbacfd87 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-B_(Myofibroblast)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.79e-06 | 177 | 118 | 6 | 43ba6f12c2fb32698a420bf799d46ac1b558f146 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.85e-06 | 181 | 118 | 6 | 8950844b3e65c7028d80da5787ae2ce509c3d52d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-06 | 182 | 118 | 6 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 185 | 118 | 6 | 4e40d3103ebf4a7066b7ce300b6ef700ba0e2863 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 186 | 118 | 6 | 16092819e9148dfe64f07c737652b6e533e699f7 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 1.03e-05 | 186 | 118 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 187 | 118 | 6 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 190 | 118 | 6 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-RGCs_early_2|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.20e-05 | 191 | 118 | 6 | 06107849463a1ccb78a5ccd3ae31619ef6bedda3 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.20e-05 | 191 | 118 | 6 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_chondroblast_(18)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.20e-05 | 191 | 118 | 6 | 273c4a757292a9301de0eaeacdec91c9866be229 | |
| ToppCell | Basal_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.20e-05 | 191 | 118 | 6 | a98915bad9a4a61dd4cbca798914849b805f4a19 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.20e-05 | 191 | 118 | 6 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-05 | 193 | 118 | 6 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | 316ebdf15f75d88c348f909b643fcd315364ca84 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | 1afdd3f7d703f4204a2cbfe40e135ac7b09213f7 | |
| ToppCell | droplet-Fat-Scat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 193 | 118 | 6 | 8dc6db335678f3a5cfd36026ad811fed8d9cb4bc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.39e-05 | 196 | 118 | 6 | 772a5851cbcc36b2075bd2ffbf8c9afa9b4b6eb7 | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.43e-05 | 197 | 118 | 6 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.43e-05 | 197 | 118 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.47e-05 | 198 | 118 | 6 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Parenchyma_COVID-19|World / Sample group, Lineage and Cell type | 1.47e-05 | 198 | 118 | 6 | 45ab554e6d0399b3182f089a25b2adf96de1144b | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-05 | 199 | 118 | 6 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 199 | 118 | 6 | 59fe5f3c6338e019a149ab135acf9cc5657298bf | |
| ToppCell | proximal-Epithelial-Proliferating_Basal-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-05 | 199 | 118 | 6 | e8549b2c4152cb23548351d9cee27c3805892cd8 | |
| ToppCell | proximal-3-Epithelial-Proliferating_Basal|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-05 | 199 | 118 | 6 | 2263bb73d9c5693b44d91d2548305efc1b6e4079 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-F-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-05 | 199 | 118 | 6 | 136f24597ddca5cf2175120975c94782a3232ec6 | |
| ToppCell | (5)_Fibroblasts|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.56e-05 | 200 | 118 | 6 | 22c839f27d3abdf86bfabdfa305f205dd899a9dc | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.56e-05 | 200 | 118 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 118 | 6 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | 356C-Fibroblasts|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 200 | 118 | 6 | 9c95329f0b26ff378de803030d4c28517b3adc85 | |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | 1.56e-05 | 200 | 118 | 6 | dec9ce1bc2571197003596f32e5f742ede72aa79 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.56e-05 | 200 | 118 | 6 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | TCGA-Thymus-Primary_Tumor-Thymoma-Type_B3-5|TCGA-Thymus / Sample_Type by Project: Shred V9 | 1.71e-05 | 120 | 118 | 5 | 9d4e630e1d3b9adf94a1884071bfe46edaa3f0c1 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Rrad|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.34e-05 | 138 | 118 | 5 | b3a040c5d0e1cc94d9b19155bca8700edba2d243 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 3.58e-05 | 140 | 118 | 5 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.96e-05 | 143 | 118 | 5 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.38e-05 | 146 | 118 | 5 | 40784fd7ef856f64edfb5a054c0c5d95c8150b20 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.82e-05 | 155 | 118 | 5 | 8e239470799426ea474a36f57e1b7e0d9365ca5f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-05 | 162 | 118 | 5 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | Bronchial-10x5prime-Stromal-Schwann|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.17e-05 | 162 | 118 | 5 | afffecc6c504930554aafc12c5bffa53e3c5b016 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-05 | 162 | 118 | 5 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.17e-05 | 162 | 118 | 5 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.05e-05 | 166 | 118 | 5 | f742d15b02a6f651bbd00f53e3d871f40d05a03d | |
| ToppCell | Basal_cells-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 8.05e-05 | 166 | 118 | 5 | 23c04d1fba0c1733ccd0e4378fae2edde4fd0a7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.05e-05 | 166 | 118 | 5 | 0f013bb5fdb72e88c2fc73d60cd01551a2db6341 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell-Schwann_Cell_/_Neural|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.05e-05 | 166 | 118 | 5 | e941df9a1091164edde3def8fc7d410186b2bd88 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Neural-neural_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.05e-05 | 166 | 118 | 5 | aeda46bea5d8463c24a83b98b9ed92d962d733e5 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.51e-05 | 168 | 118 | 5 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.75e-05 | 169 | 118 | 5 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-05 | 170 | 118 | 5 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.00e-05 | 170 | 118 | 5 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.00e-05 | 170 | 118 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.25e-05 | 171 | 118 | 5 | 05014cf6746e6663e376fdd681f1b43a7081c603 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.25e-05 | 171 | 118 | 5 | d6114db2292fbb27b39d090d51fd305a135b1ccf | |
| ToppCell | MS-CD8-proli_CD4|MS / Condition, Cell_class and T cell subcluster | 9.51e-05 | 172 | 118 | 5 | 0b6dd257110b3f17fa71ab18a165b091a9d5ae9a | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-secretory_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 173 | 118 | 5 | 766e712e4db440468a32971459c1d3354add611f | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-Reg4/cKit+_deep_crypt_secretory_cells_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.77e-05 | 173 | 118 | 5 | 40ef91afb366e87b5ba2951d2578ebfe04d042c0 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte-3|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 174 | 118 | 5 | 76310c0af1d7df6a4de3816838b2ac2892f68746 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.00e-04 | 174 | 118 | 5 | 7b2f35add804981c7d588a996bdbca6ec11a1ca5 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-04 | 176 | 118 | 5 | 1f8d5a48fedbb4c86272c9b5a0f1ef573350357b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 177 | 118 | 5 | 3e149bff1f1b393a7abe98984e37981c8296f95d | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_macrophage-stroma-erythroid_macrophage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.15e-04 | 179 | 118 | 5 | c17ae394b855f01f8ca1765c416fd8b34a96e60b | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 180 | 118 | 5 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-04 | 180 | 118 | 5 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 180 | 118 | 5 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-monocyte_+_promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 180 | 118 | 5 | c54af6fb11484dacd3efa1f10a487376ff820a5e | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.18e-04 | 180 | 118 | 5 | 07ac979b21be2425294d9818c48b5a1e6f014c19 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-04 | 181 | 118 | 5 | ebf1ae963a2b22e1772752ed85a4fb0e546d377e | |
| ToppCell | Mesenchymal_cells-Stromal_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.21e-04 | 181 | 118 | 5 | f8d914fdc06aaa75a4dc9158daf574ca28fa5432 | |
| ToppCell | Pericytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-04 | 181 | 118 | 5 | 35c470988a93381eefa300831aabb813fa1b90bd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 181 | 118 | 5 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | PND01-03-samps-Mesenchymal-Myofibroblast|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 1.24e-04 | 182 | 118 | 5 | 812dac35b9aa05be48258082e007f6c00e7b4dd8 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.24e-04 | 182 | 118 | 5 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.27e-04 | 183 | 118 | 5 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.30e-04 | 184 | 118 | 5 | d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 1.30e-04 | 184 | 118 | 5 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | tumor_Lung-Fibroblasts-Mesothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 1.30e-04 | 184 | 118 | 5 | b0a251030d127858e68cf164be158f209a4d720f | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.34e-04 | 185 | 118 | 5 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 186 | 118 | 5 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-04 | 186 | 118 | 5 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | d1dc8c9a2c2cd10c640257161a75e7730ec5bb41 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | 15d6e158562d7d85af3ceaf955439b379c8fce81 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-04 | 187 | 118 | 5 | f62074b631fd45ad299c69d71b09267b04d656ee | |
| Computational | Cytochrome P450. | 2.31e-06 | 14 | 77 | 4 | MODULE_106 | |
| Drug | 4',5-dihydroxydiclofenac | 9.86e-09 | 6 | 117 | 4 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 9.86e-09 | 6 | 117 | 4 | CID000112230 | |
| Drug | 5-hydroxydiclofenac | 3.18e-07 | 12 | 117 | 4 | CID003052566 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 8.65e-07 | 15 | 117 | 4 | ctd:C586542 | |
| Drug | bufuralol | 1.31e-06 | 5 | 117 | 3 | ctd:C010831 | |
| Drug | Azamulinum | 1.92e-06 | 18 | 117 | 4 | CID003086060 | |
| Drug | D 703 | 1.92e-06 | 18 | 117 | 4 | CID000054088 | |
| Drug | hydroxytolbutamide | 2.42e-06 | 19 | 117 | 4 | CID000003656 | |
| Drug | 6|A-Hydroxycortisol | 2.42e-06 | 19 | 117 | 4 | CID000150985 | |
| Drug | 4,4'-cyclohexylidenebisphenol | 2.62e-06 | 6 | 117 | 3 | ctd:C570106 | |
| Drug | AC1O5Z5L | 2.62e-06 | 6 | 117 | 3 | CID006443527 | |
| Drug | N'-nitrosoanatabine | 3.01e-06 | 20 | 117 | 4 | CID000051291 | |
| Drug | 3C etc | 3.01e-06 | 20 | 117 | 4 | CID000164045 | |
| Drug | N'-nitrosoanabasine | 4.51e-06 | 22 | 117 | 4 | CID000014335 | |
| Drug | 16-O-demethylaconitine | 4.56e-06 | 7 | 117 | 3 | ctd:C486136 | |
| Drug | 5-fluorotryptamine | 4.56e-06 | 7 | 117 | 3 | ctd:C034536 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 4.56e-06 | 7 | 117 | 3 | CID005486899 | |
| Drug | 3-hydroxymethylantipyrine | 5.44e-06 | 23 | 117 | 4 | CID000123963 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 7.27e-06 | 8 | 117 | 3 | CID006439499 | |
| Drug | 11-HODE | 7.27e-06 | 8 | 117 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 7.27e-06 | 8 | 117 | 3 | ctd:C040997 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 7.27e-06 | 8 | 117 | 3 | ctd:C585955 | |
| Drug | Tolbutamide | 7.71e-06 | 25 | 117 | 4 | ctd:D014044 | |
| Drug | 1,4-naphthoquinone | 9.07e-06 | 26 | 117 | 4 | ctd:C035342 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 1.09e-05 | 9 | 117 | 3 | ctd:C545880 | |
| Drug | Acenocoumarol | 1.09e-05 | 9 | 117 | 3 | ctd:D000074 | |
| Drug | Tryptamines | 1.09e-05 | 9 | 117 | 3 | ctd:D014363 | |
| Drug | 5-chlorotryptamine | 1.09e-05 | 9 | 117 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 1.09e-05 | 9 | 117 | 3 | ctd:C109602 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 1.09e-05 | 9 | 117 | 3 | ctd:C000588958 | |
| Drug | (hydrochloride) | 1.42e-05 | 29 | 117 | 4 | CID000004923 | |
| Drug | norketobemidone | 1.55e-05 | 10 | 117 | 3 | CID000161154 | |
| Drug | sitaxsentan | 1.55e-05 | 10 | 117 | 3 | ctd:C106276 | |
| Drug | chlorzoxazone | 1.82e-05 | 63 | 117 | 5 | CID000002733 | |
| Drug | Haloperidol metabolite I | 2.12e-05 | 11 | 117 | 3 | CID000038282 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 2.12e-05 | 11 | 117 | 3 | ctd:C507866 | |
| Drug | BP-7,8-oxide | 2.13e-05 | 32 | 117 | 4 | CID000037455 | |
| Drug | dibenzylfluorescein | 2.62e-05 | 2 | 117 | 2 | ctd:C558664 | |
| Drug | 4-(N-propionylanilino)piperidine | 2.81e-05 | 12 | 117 | 3 | CID000259381 | |
| Drug | carveol | 2.81e-05 | 12 | 117 | 3 | CID000007438 | |
| Drug | desethylamodiaquine | 2.81e-05 | 12 | 117 | 3 | ctd:C047386 | |
| Drug | norclozapine | 2.81e-05 | 12 | 117 | 3 | ctd:C058272 | |
| Drug | AC1L18GM | 3.64e-05 | 13 | 117 | 3 | CID000000092 | |
| Drug | 7-hydroxyquinoline | 3.64e-05 | 13 | 117 | 3 | CID000011378 | |
| Drug | 1'-hydroxymidazolam | 3.64e-05 | 13 | 117 | 3 | CID000107917 | |
| Drug | clozapine N-oxide | 3.64e-05 | 13 | 117 | 3 | CID000036727 | |
| Drug | primidone | 3.84e-05 | 37 | 117 | 4 | CID000004909 | |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 4.55e-05 | 183 | 117 | 7 | 1475_UP | |
| Drug | propionanilide | 4.62e-05 | 14 | 117 | 3 | CID000012107 | |
| Drug | 5-MeO-DIPT | 4.62e-05 | 14 | 117 | 3 | CID000151182 | |
| Drug | emend | 5.25e-05 | 40 | 117 | 4 | CID000151165 | |
| Drug | chloral hydrate | 5.51e-05 | 129 | 117 | 6 | CID000002707 | |
| Drug | 4-hydroxymephenytoin | 5.75e-05 | 15 | 117 | 3 | CID000119507 | |
| Drug | furafylline | 5.79e-05 | 41 | 117 | 4 | CID000003433 | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; HL60; HT_HG-U133A | 7.02e-05 | 196 | 117 | 7 | 1872_UP | |
| Drug | 4,4'-(hexafluoroisopropylidene)diphenol | 7.05e-05 | 16 | 117 | 3 | ctd:C571725 | |
| Drug | HCFC-141b | 7.05e-05 | 16 | 117 | 3 | CID000015586 | |
| Drug | 6-hydroxychlorzoxazone | 7.05e-05 | 16 | 117 | 3 | CID000002734 | |
| Drug | Amodiaquine | 7.05e-05 | 16 | 117 | 3 | ctd:D000655 | |
| Drug | 1-phenylazo-2-naphthol | 7.05e-05 | 16 | 117 | 3 | ctd:C024336 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 7.05e-05 | 16 | 117 | 3 | ctd:C495657 | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; HL60; HT_HG-U133A | 7.49e-05 | 198 | 117 | 7 | 2362_DN | |
| Drug | sulfaphenazole | 7.67e-05 | 44 | 117 | 4 | CID000005335 | |
| Drug | polybrominated biphenyl | 7.67e-05 | 44 | 117 | 4 | CID000042948 | |
| Drug | picoxystrobin | 7.83e-05 | 3 | 117 | 2 | ctd:C556557 | |
| Drug | Cyclohexenes | 7.83e-05 | 3 | 117 | 2 | ctd:D053138 | |
| Drug | mono-N-demethyladinazolam | 7.83e-05 | 3 | 117 | 2 | ctd:C050132 | |
| Drug | ortho-Aminobenzoates | 7.83e-05 | 3 | 117 | 2 | ctd:D062367 | |
| Drug | 5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione | 7.83e-05 | 3 | 117 | 2 | ctd:C502236 | |
| Drug | 2-hydroxychlorpropamide | 7.83e-05 | 3 | 117 | 2 | CID003082454 | |
| Drug | Delavirdine | 7.83e-05 | 3 | 117 | 2 | ctd:D020008 | |
| Drug | diosmetin | 8.53e-05 | 17 | 117 | 3 | ctd:C039602 | |
| Drug | 7-benzyloxyquinoline | 1.02e-04 | 18 | 117 | 3 | CID003035604 | |
| Drug | styrene glycol | 1.02e-04 | 18 | 117 | 3 | CID000007149 | |
| Drug | pleuromutilin | 1.02e-04 | 18 | 117 | 3 | CID000031326 | |
| Drug | 2,4-oxazolidinedione | 1.02e-04 | 18 | 117 | 3 | CID000097389 | |
| Drug | 19-HETE | 1.17e-04 | 49 | 117 | 4 | CID006439528 | |
| Drug | 5-ClAU | 1.21e-04 | 19 | 117 | 3 | CID000126441 | |
| Drug | poly(vA | 1.21e-04 | 19 | 117 | 3 | CID000429118 | |
| Drug | D 617 | 1.21e-04 | 19 | 117 | 3 | CID000093168 | |
| Drug | dercitin | 1.21e-04 | 19 | 117 | 3 | CID000130774 | |
| Drug | aucubigenin | 1.21e-04 | 19 | 117 | 3 | CID000163040 | |
| Drug | 6-hydroxymelatonin | 1.27e-04 | 50 | 117 | 4 | CID000001864 | |
| Drug | quindine | 1.40e-04 | 219 | 117 | 7 | CID000001065 | |
| Drug | OXT-ATP | 1.41e-04 | 20 | 117 | 3 | CID000454146 | |
| Drug | tamoxifen N-oxide | 1.41e-04 | 20 | 117 | 3 | CID003033895 | |
| Drug | AC1MHT6K | 1.41e-04 | 20 | 117 | 3 | CID003010960 | |
| Drug | 3-methoxymorphinan | 1.41e-04 | 20 | 117 | 3 | CID000001671 | |
| Drug | thiocoraline | 1.56e-04 | 4 | 117 | 2 | ctd:C109005 | |
| Drug | 1-(6-((2-(dimethylamino)ethyl)(methyl)amino)-1,3-dimethyl-1H-pyrazolo(3,4-b)pyridine-5-carbonyl)-3-(3-isopropoxyphenyl)urea | 1.56e-04 | 4 | 117 | 2 | ctd:C558737 | |
| Drug | 4-isopropylphenol | 1.56e-04 | 4 | 117 | 2 | ctd:C028690 | |
| Drug | methysticin | 1.56e-04 | 4 | 117 | 2 | ctd:C076881 | |
| Drug | Sulfadiazine | 1.56e-04 | 4 | 117 | 2 | ctd:D013411 | |
| Drug | rabeprazole-thioether | 1.56e-04 | 4 | 117 | 2 | ctd:C523099 | |
| Drug | 7,8-dihydromethysticin | 1.56e-04 | 4 | 117 | 2 | ctd:C107882 | |
| Drug | 4,4'-dinitrocarbanilide | 1.56e-04 | 4 | 117 | 2 | CID000009509 | |
| Drug | NSC615828 | 1.60e-04 | 53 | 117 | 4 | CID000002235 | |
| Drug | AC1L21VM | 1.64e-04 | 21 | 117 | 3 | CID000039524 | |
| Drug | AC1L3V16 | 1.64e-04 | 21 | 117 | 3 | CID000122664 | |
| Drug | nirvanol | 1.64e-04 | 21 | 117 | 3 | CID000091480 | |
| Disease | X-21258 measurement | 5.92e-08 | 3 | 116 | 3 | EFO_0800802 | |
| Disease | X-14473 measurement | 1.53e-05 | 2 | 116 | 2 | EFO_0021370 | |
| Disease | cyclo(leu-pro) measurement | 4.58e-05 | 3 | 116 | 2 | EFO_0800676 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 9.90e-05 | 23 | 116 | 3 | EFO_0004985, GO_1903493 | |
| Disease | familial hemiplegic migraine (implicated_via_orthology) | 3.18e-04 | 7 | 116 | 2 | DOID:0060178 (implicated_via_orthology) | |
| Disease | phosphate measurement | 3.18e-04 | 7 | 116 | 2 | EFO_0010968 | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 3.18e-04 | 7 | 116 | 2 | EFO_0800655 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 4.10e-04 | 88 | 116 | 4 | EFO_0803332 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 5.42e-04 | 9 | 116 | 2 | EFO_0600040 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 5.48e-04 | 95 | 116 | 4 | EFO_0803331 | |
| Disease | Cleft palate, isolated | 6.08e-04 | 42 | 116 | 3 | C1837218 | |
| Disease | X-11308 measurement | 8.23e-04 | 11 | 116 | 2 | EFO_0800693 | |
| Disease | nervous system disease (implicated_via_orthology) | 9.86e-04 | 12 | 116 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | thymol sulfate measurement | 9.86e-04 | 12 | 116 | 2 | EFO_0021170 | |
| Disease | Malignant neoplasm of breast | SFRP2 UBE2C PCDHB15 SMC6 LRRC37A2 PKDREJ LRRC37A IL1RAPL2 FGF3 MAP3K13 TP53BP1 DOP1A | 1.08e-03 | 1074 | 116 | 12 | C0006142 |
| Disease | ecosanoids measurement | 1.34e-03 | 55 | 116 | 3 | EFO_0020044 | |
| Disease | Down syndrome (implicated_via_orthology) | 1.56e-03 | 15 | 116 | 2 | DOID:14250 (implicated_via_orthology) | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 1.56e-03 | 15 | 116 | 2 | EFO_0800301 | |
| Disease | phosphorus measurement | 1.77e-03 | 16 | 116 | 2 | EFO_0004861 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 1.77e-03 | 16 | 116 | 2 | EFO_0800305 | |
| Disease | Multiple congenital anomalies | 2.00e-03 | 17 | 116 | 2 | C0000772 | |
| Disease | food allergy measurement, parental genotype effect measurement | 2.25e-03 | 18 | 116 | 2 | EFO_0005939, EFO_0007016 | |
| Disease | synophrys measurement | 2.46e-03 | 68 | 116 | 3 | EFO_0007906 | |
| Disease | metabolonic lactone sulfate measurement | 2.51e-03 | 19 | 116 | 2 | EFO_0800659 | |
| Disease | Headache, HbA1c measurement | 3.06e-03 | 21 | 116 | 2 | EFO_0004541, HP_0002315 | |
| Disease | prostate cancer (is_marker_for) | 3.40e-03 | 156 | 116 | 4 | DOID:10283 (is_marker_for) | |
| Disease | Etat Marbre | 3.67e-03 | 23 | 116 | 2 | C0266487 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ESETLDQLPLTNPEH | 116 | Q4LE39 | |
| TPQLHFLDTDDEVSP | 471 | Q86US8 | |
| LLFSNNTQELHPDPF | 606 | Q9UBC2 | |
| ESETLDQLPLTNPEH | 116 | P29374 | |
| HDTLELQLSSPPARD | 1671 | Q6UVK1 | |
| LTSVLHDDKEFPNPN | 391 | P10632 | |
| DLQTEPPFSKDHAQL | 391 | Q5JWR5 | |
| PPLASLQDSHFLTDA | 116 | P18075 | |
| PTHLSLDPTNAENTA | 161 | Q9UER7 | |
| NFLDLTVPESNKHEP | 146 | P56880 | |
| QTPHLLLTEDDPQSQ | 126 | Q8WWK9 | |
| HTLDDVPSAAPQLSL | 521 | Q8TDY8 | |
| LEDRHSLDSNTPLFP | 1331 | Q6ZS30 | |
| DSLQEVLPDFSDHPT | 666 | Q9Y5F8 | |
| HEDSTTPVANPLLAF | 76 | Q7Z4N8 | |
| LESIPTDNPEAHSNL | 796 | Q12851 | |
| HLPTEALAPADSLND | 1711 | P51610 | |
| SQFHLEPETQNPETL | 216 | O60309 | |
| SQFHLEPETQNPETL | 216 | A6NM11 | |
| SQFHLEPETQNPETL | 216 | A6NMS7 | |
| QPDHPDLLTGDLTLN | 271 | Q6P4R8 | |
| QQSAPLEESEHLPLS | 341 | P50391 | |
| DRLPPIHQFSIESDT | 96 | Q9Y6K8 | |
| SDSLDNIEAPHFPLP | 526 | Q96S65 | |
| DLNQFLSRHEPPNSS | 661 | Q16832 | |
| FLLPPDESLHSLQSR | 326 | O15111 | |
| SPDNLEPSHVQASRL | 216 | P11487 | |
| TPQFEDHFPQSIDVL | 711 | Q9NYQ8 | |
| NPDEAHTNSAILPLL | 671 | Q9NZN1 | |
| TSELALNTFDHNPDP | 201 | Q8IYT4 | |
| LNTFDHNPDPSERLL | 206 | Q8IYT4 | |
| LSSDPSLPALADFHQ | 396 | Q9H6R4 | |
| DHNALESVPLNLPES | 221 | P20774 | |
| DDNSLTEVPVHPLSN | 161 | Q9BXB1 | |
| NTETATHEAEPPLFQ | 111 | Q6ZVL6 | |
| ELDSPQLHFSLPTDP | 1431 | Q9UKK3 | |
| LLVTDINDHSPEFPE | 121 | Q9Y5E8 | |
| TSSLFKNNPDIPELH | 201 | Q9H8H2 | |
| SEPHLNTPAFSLVED | 146 | Q96PC2 | |
| DPNVDEHLSTQILAP | 11 | Q96MC2 | |
| LAPELFESQPDLLHQ | 521 | P29375 | |
| NDHSPRFPLDSLQLD | 161 | Q6V1P9 | |
| NTLDLIAPSPADAQH | 106 | P51178 | |
| DAPPNLTASLFTHSE | 271 | P53539 | |
| DLSKSPAHNPLLENA | 756 | O43283 | |
| QHLQALLTPDEPDNS | 181 | Q9H094 | |
| HLDSPSQTFPEQLSP | 541 | Q8IUM7 | |
| SPEFTHENPLETRNI | 226 | P50993 | |
| DLISLSHEPPVQDFI | 1926 | P42858 | |
| LTSVLHDNKEFPNPE | 391 | P33261 | |
| SPQSLDISFAIHPED | 246 | Q8N0S6 | |
| STETPNSEFLQALHP | 221 | I3L273 | |
| NSEFLQALHPDPSKT | 226 | I3L273 | |
| NALLDHPEELQPSES | 196 | Q9BPX7 | |
| LAEFQSPLHSPLDSS | 81 | Q53ET0 | |
| PNNHSVILIDDFESP | 316 | Q495W5 | |
| LLPETAHPDAAFQLT | 466 | Q96SY0 | |
| HQSLQPSADRPLEAS | 676 | P57058 | |
| SHPLDLSPNVQSRDA | 1021 | Q9ULH1 | |
| DSQAHPPELLFSASL | 556 | O00754 | |
| LLHNIDPNFVDSSPC | 391 | P15848 | |
| LTSVLHNDKEFPNPE | 391 | P33260 | |
| EAPSNPHFSLLDIQD | 541 | Q9UJ99 | |
| SEHINLPLPENDFSD | 281 | Q6PJP8 | |
| ILTEPPTEDHLLQNT | 541 | Q6IA86 | |
| LTSVLHDNKEFPNPE | 391 | P11712 | |
| PQHSFASLPLNESER | 1401 | Q9C0D2 | |
| ENNQPEPLHLFLSSA | 116 | Q9NV23 | |
| DPLFVLEHSLPIDTQ | 941 | P28340 | |
| DLSPHTSPFQAQLTD | 571 | P22223 | |
| VSSFILPHRPDNEES | 791 | Q13822 | |
| ARPETFPNSLESHND | 251 | Q96JN8 | |
| DPHLPLASLVSINTD | 496 | Q9UN66 | |
| HLAHPNLDTFTPEEL | 26 | Q96CV9 | |
| AQPLQPSHFLDISED | 186 | Q9HBJ0 | |
| PADHLLLPSQEESFS | 881 | Q6WKZ4 | |
| PQDNDLCIPLASSDH | 146 | Q96HF1 | |
| PPLSTNLHLESELDA | 816 | Q9UPN9 | |
| PDNHLSPQNDDALET | 456 | O94972 | |
| QLHRLSLESSPDAPD | 431 | Q494U1 | |
| EVEELLPQHLQPSSS | 1021 | O43426 | |
| LVSSQADLPEFHPSD | 596 | Q9NP60 | |
| LLHNDLNPTFLPESS | 1771 | Q9NTG1 | |
| FDDSLPNPHELVSDL | 356 | O94768 | |
| AAPPELQPHSESSDL | 416 | Q14190 | |
| LPPEHQSLKSSFEAL | 1071 | Q9NQW1 | |
| LDQPINTTDLPFHID | 616 | P40879 | |
| DPLHVIENSNAFSTP | 551 | Q9H0H5 | |
| EDESQSSQPLLQAPH | 1611 | Q8IY92 | |
| DCPSELQHTQELFPQ | 56 | Q9UHE8 | |
| SPDFTHENPLETRNI | 236 | Q13733 | |
| NSSTHLLDLLDEPIP | 66 | P51790 | |
| PSDHFSLLTQLELHP | 526 | Q96LI5 | |
| SPPASLDHEAPSLQE | 881 | Q8IXZ2 | |
| LQSSPLEDLLIEHPS | 91 | Q8IXH6 | |
| VDLQTFPSSRDDLHP | 1306 | O60673 | |
| PSLDFLADPDTVNHL | 281 | Q9Y5W7 | |
| CPQPLEFDTNQDTHL | 711 | P41226 | |
| HSDLISFQPTDSDIP | 926 | Q12767 | |
| VPPSIQDLTDHDLFA | 686 | Q9H7N4 | |
| PLVDFVELPDNHSSL | 111 | O43617 | |
| QTDPEHPDNDRFILS | 61 | Q9H0I9 | |
| ELSDQPENTFLHPII | 371 | P05543 | |
| LNHSFSLTDLQDDIP | 201 | Q9Y385 | |
| SNFELNPDLHLPAEN | 646 | O43847 | |
| QQSAPLEESEHLPLS | 341 | P0DQD5 | |
| HPDFPTVLTALEIDN | 581 | Q96SB8 | |
| HTLPTQEEIENLPAF | 1926 | P08922 | |
| FSHDIFIPSPSLEEQ | 456 | Q12888 | |
| PLLQSEPSLTSDELH | 376 | Q8IZN3 | |
| QLDLSHNPLADLSPF | 146 | Q13641 | |
| LESPEHLPSNFLAQP | 266 | Q6ZSB9 | |
| DLHPSTPLKTLFQND | 41 | Q6ZXV5 | |
| EFSLPQPSLHDLTQD | 1006 | O60293 | |
| RQPAVHPENLSLDSS | 16 | Q7Z402 | |
| EPNIDSPLNTHAAEL | 141 | O00762 | |
| LEPENTLDQHSFSLP | 461 | O43264 | |
| HLNQTDPPDIDINAT | 346 | Q9NR99 | |
| EENRLPQPSDQHFTS | 531 | Q9UM54 | |
| PSSPSAQLRDLDTHQ | 541 | Q8NFW9 |